Low-renin (volume dependent) mild-hypertensive patients have impaired flow-mediated and glyceryl-trinitrate stimulated vascular reactivity

Circulation Journal

Volumn 69, Issue 11, 2005, Pages 1380-1385

  Yugar Toledo, Juan Carlos ^a   Bonalume Tácito, Lúcia Helena ^a   Ferreira Melo, Sílvia Elaine ^a   Sousa, Walnéia ^a   Consolin Colombo, Fernanda ^b   Irigoyen, Maria Cláudia ^b   Franchini, Kléber ^a   Coelho, Otávio Rizzi ^a   Moreno Jr , Heitor ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Angiotensin II; Low renin (volume dependent) hypertension; Nitric oxide; Vascular reactivity

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; GLYCERYL TRINITRATE; NITRATE; NITRITE; RENIN;

ADULT; ALDOSTERONE BLOOD LEVEL; ARTERY BLOOD FLOW; ARTERY INTIMA; ARTERY MEDIA; ARTICLE; BLOOD VESSEL REACTIVITY; BRACHIAL ARTERY; CAROTID ARTERY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; HUMAN; HYPEREMIA; HYPERTENSION; MALE; PLASMA RENIN ACTIVITY; VASODILATATION;

ADULT; BRACHIAL ARTERY; CAROTID ARTERY, COMMON; CASE-CONTROL STUDIES; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; NITROGLYCERIN; RENIN; TUNICA INTIMA; VASODILATION; VASODILATOR AGENTS;

EID: 27644487846     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.69.1380     Document Type: Article

References (52)

1. Drexler H. Endothelial dysfunction: Clinical implications. Prog Cardiovasc Dis 1997; 39: 287 - 324.
2. Egashira K. Clinical importance of endothelial function in arteriosclerosis and ischemic heart disease. Circ J 2002; 66: 529 - 533.
3. Vanhoutte PM. Endothelial control of vasomotor function: From health to coronary disease. Circ J 2003; 67: 572 - 575.
4. Gibbons GH, Dzau VJ. The emerging concept of vascular remodeling. N Engl J Med 1994; 330: 1431 - 1438.
5. Taddei S, Virdis A, Ghiadoni L, Salvetti G, Salvetti A. Endothelial dysfunction in hypertension. J Nephrol 2000; 13: 205 - 210.
6. Ueno H, Kanellakis P, Agrotis A, Bobik A. Blood flow regulates the development of vascular hypertrophy, smooth muscle cell proliferation, and endothelial cell nitric oxide synthase in hypertension. Hypertension 2000; 36: 89 - 96.
7. Panza JA, Quyyumi AA, Brush JE Jr, Epstein SE. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med 1990; 323: 22 - 27.
8. Panza JA, Casino PR, Kilcoyne CM, Quyyumi AA. Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993; 87: 1468 - 1474.
9. Panza JA. Endothelial dysfunction in essential hypertension. Clin Cardiol 1997; 20(Suppl II): II-26 - II-33.
10. Laragh J. Laragh's lessons in pathophysiology and clinical pearls for treating hypertension. Am J Hypertens 2001; 14: 186 - 194.
11. Drayer JI, Weber MA, Sealey JE, Laragh JH. Low and high renin essential hypertension: A comparison of clinical and biochemical characteristics. Am J Med Sci 1981; 281: 135 - 142.
12. Drayer JI, Weber MA, Laragh JH, Sealey JE. Renin subgroups in essential hypertension. Clin Exp Hypertens A 1982; 4: 1817 - 1834.
13. Laragh JH. Renin-angiotensin-aldosterone system for blood pressure and electrolyte homeostasis and its involvement in hypertension, in congestive heart failure and in associated cardiovascular damage (myocardial infarction and stroke). J Hum Hypertens 1995; 9: 385 - 390.
14. Chen PY, Sanders PW. L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 1991; 88: 1559 - 1567.
15. Stein CM, Nelson R, Brown M, Wood M, Wood AJ. Dietary sodium intake modulates vasodilation mediated by nitroprusside but not by methacholine in the human forearm. Hypertension 1995; 25: 1220 - 1223.
16. Miyoshi A, Suzuki H, Fujiwara M, Masai M, Iwasaki T. Impairment of endothelial function in salt-sensitive hypertension in humans. Am J Hypertens 1997; 10(Pt 1): 1083 - 1090.
17. Bragulat E, de la Sierra A, Antonio MT, Coca A. Endothelial dysfunction in salt-sensitive essential hypertension. Hypertension 2001; 37(Part 2): 444 - 448.
18. Gamble G, Beaumont B, Smith H, Zorn J, Sanders G, Merrilees M, et al. B-mode ultrasound images of the carotid artery wall: Correlation of ultrasound with histological measurements. Atherosclerosis 1993; 102: 163 - 173.
19. Bots ML, Mulder PG, Hofman A, van Es GA, Grobbee DE. Reproducibility of carotid vessel wall thickness measurements: The Rotterdam Study. J Clin Epidemiol 1994; 47: 921 - 930.
20. Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: The Rotterdam Study. Circulation 1997; 96: 1432 - 1437.
21. O'Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults: Cardiovascular Health Study Collaborative Research Group. N Engl J Med 1999; 340: 14 - 22.
22. Neunteufl T, Maurer G. Noninvasive ultrasound techniques for the assessment of atherosclerosis in coronary artery disease. Circ J 2003; 67: 177 - 186.
23. Esen AM, Barutcu I, Acar M, Degirmenci B, Kaya D, Turkmen M, et al. Effect of smoking on endothelial function and wall thickness of brachial artery. Circ J 2004; 68: 1123 - 1126.
24. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA 2003; 289: 2560 - 2572.
25. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001; 285: 2486 - 2497.
26. Resnick HE, Harris MI, Brock DB, Harris TB. American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: Results from the Third National Health and Nutrition Examination Survey. Diabetes Care 2000; 23: 176 - 180.
27. Salvetti A, Pedrinelli R, Magagna A, Poli L, Sassano P, Arzilli F. Influence of age and sodium intake on plasma renin activity of normal subjects. Nephron 1980; 26: 189 - 194.
28. Green LC, Wagner DA, Glogowski J, Skipper PL, Wishnok JS, Tannenbaum SR. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131 - 138.
29. Celermajer DS, Sorensen KE, Gooch VM, Spiegelhalter DJ, Miller OI, Sullivan ID, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111 - 1115.
30. Corretti MC, Anderson TJ, Benjamin EJ, Celermajer D, Charbonneau F, Creager MA, et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: A report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002; 39: 257 - 265.
31. Yugar-Toledo JC, Tanus-Santos JE, Sabha M, Sousa MG, Cittadino M, Tacito LH, et al. Uncontrolled hypertension, uncompensated type II diabetes, and smoking have different patterns of vascular dysfunction. Chest 2004; 125: 823 - 830.
32. Sorensen KE, Celermajer DS, Spiegelhalter DJ, Georgakopoulos D, Robinson J, Thomas O, et al. Non-invasive measurement of human endothelium dependent arterial responses: Accuracy and reproducibility. Br Heart J 1995; 74: 247 - 253.
33. Adams MR, Robinson J, McCredie R, Seale JP, Sorensen KE, Deanfield JE, et al. Smooth muscle dysfunction occurs independently of impaired endothelium-dependent dilation in adults at risk of atherosclerosis. J Am Coll Cardiol 1998; 32: 123 - 127.
34. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: A direct measurement with ultrasound imaging. Circulation 1986; 74: 1399 - 1406.
35. Salonen R, Salonen JT. Progression of carotid atherosclerosis and its determinants: A population-based ultrasonography study. Atherosclerosis 1990; 81: 33 - 40.
36. Kazmierski R, Watala C, Lukasik M, Kozubski W. Common carotid artery remodeling studied by sonomorphological criteria. J Neuroimaging 2004; 14: 258 - 264.
37. Jaimes EA, Sweeney C, Raij L. Effects of the reactive oxygen species hydrogen peroxide and hypochlorite on endothelial nitric oxide production. Hypertension 2001; 38: 877 - 883.
38. Raij L. Workshop: Hypertension and cardiovascular risk factors: Role of the angiotensin II-nitric oxide interaction. Hypertension 2001; 37(Part 2): 767 - 773.
39. Heistad DD. A radical view on the 'superfamily' of cardiovascular risk factors (Mikamo Lecture). Circ J 2003; 67: 805 - 809.
40. Adam A, Raij L. Nitric oxide - angiotensin II axis in renal and cardiovascular injury. J Nephrol 2000; 13: 211 - 220.
41. Yan C, Kim D, Aizawa T, Berk BC. Functional interplay between angiotensin II and nitric oxide: Cyclic GMP as a key mediator. Arterioscler Thromb Vasc Biol 2003; 23: 26 - 36.
42. Higashi Y, Sasaki S, Nakagawa K, Kimura M, Noma K, Sasaki S, et al. Sodium chloride loading does not alter endothelium-dependent vasodilation of forearm vasculature in either salt-sensitive or saltresistant patients with essential hypertension. Hypertens Res 2001; 24: 711 - 716.
43. Raij L. Nitric oxide, salt sensitivity, and cardiorenal injury in hypertension. Semin Nephrol 1999; 19: 296 - 303.
44. Fisher ND, Hurwitz S, Ferri C, Jeunemaitre X, Hollenberg NK, Williams GH. Altered adrenal sensitivity to angiotensin II in volumedependent essential hypertension. Hypertension 1999; 34: 388 - 394.
45. Fujiwara N, Osanai T, Kamada T, Katoh T, Takahashi K, Okumura K. Study on the relationship between plasma nitrite and nitrate level and salt sensitivity in human hypertension: Modulation of nitric oxide synthesis by salt intake. Circulation 2000; 101: 856 - 861.
46. Zhou MS, Schulman IH, Raij L. Nitric oxide, angiotensin II, and hypertension. Semin Nephrol 2004; 24: 366 - 378.
47. Hatakeyama H, Miyamori I, Fujita T, Takeda Y, Takeda R, Yamamoto H. Vascular aldosterone: Biosynthesis and a link to angiotensin II-induced hypertrophy of vascular smooth muscle cells. J Biol Chem 1994; 269: 24316 - 24320.
48. Rocha R, Funder JW. The pathophysiology of aldosterone in the cardiovascular system. Ann N Y Acad Sci 2002; 970: 89 - 100.
49. Oberleithner H, Ludwig T, Riethmuller C, Hillebrand U, Albermann L, Schafer C, et al. Human endothelium: Target for aldosterone. Hypertension 2004; 43: 952 - 956.
50. Sasaki R, Yamano S, Yamamoto Y, Minami S, Yamamoto J, Nakashima T, et al. Vascular remodeling of the carotid artery in patients with untreated essential hypertension increases with age. Hypertens Res 2002; 25: 373 - 379.
51. Cittadino M, Goncalves de Sousa M, Ugar-Toledo JC, Rocha JC, Tanus-Santos JE, Moreno H Jr. Biochemical endothelial markers and cardiovascular remodeling in refractory arterial hypertension. Clin Exp Hypertens 2003; 25: 25 - 33.
52. Agata J, Nagahara D, Kinoshita S, Takagawa Y, Moniwa N, Yoshida D, et al. Angiotensin II receptor blocker prevents increased arterial stiffness in patients with essential hypertension. Circ J 2004; 68: 1194 - 1198.